Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Infusion of donor leukocytes to induce tolerance in organ allograft recipients

Salgar, SK and Shapiro, R and Dodson, F and Corry, R and McCurry, K and Zeevi, A and Pham, S and Abu-Elmagd, K and Reyes, J and Jordan, M and Keenan, R and Griffith, B and Sesky, T and Ostrowski, L and Starzl, TE and Fung, JJ and Rao, AS (1999) Infusion of donor leukocytes to induce tolerance in organ allograft recipients. Journal of Leukocyte Biology, 66 (2). 310 - 314. ISSN 0741-5400

Accepted Version
Available under License : See the attached license file.

Download (928kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)


To further enhance chimerism, 229 primary allograft recipients have received perioperative intravenous infusion of a single dose of 3 to 6 x 108 unmodified donor bone marrow (BM) cells/kg body weight. In addition, 42 patients have been accrued in a concurrent protocol involving multiple (up to three) sequential perioperative infusions of 2 x 108 BM cells/kg/day from day 0-2 posttransplantation (PTx). Organ recipients (n = 133) for whom BM was not available were monitored as controls. The infusion of BM was safe and except for 50 (18%), all study patients have optimal graft function. Of the control patients, allografts in 30 (23%) have been lost during the course of follow-up. The cumulative risk of acute cellular rejection (ACR) was statistically lower in the study patients compared with that of controls. It is interesting that, 62% of BM-augmented heart recipients were free of ACR (Grade ≥ 3A) in the first 6 months PTx compared to controls. The incidence of obliterative bronchiolitis was also statistically lower in study lung recipients (3.8%) compared with the contemporaneously acquired controls (31%). The levels of donor cell chimerism were at least a log higher in the peripheral blood of majority of the study patients compared with that of controls. The incidence of donor-specific hyporeactivity, as determined by one-way mixed leukocyte reaction, was also higher in those BM-augmented liver, kidney, and lung recipients that could be evaluated compared to controls.


Social Networking:
Share |


Item Type: Article
Status: Published
CreatorsEmailPitt UsernameORCID
Salgar, SK
Shapiro, R
Dodson, F
Corry, R
McCurry, K
Zeevi, A
Pham, S
Abu-Elmagd, K
Reyes, J
Jordan, M
Keenan, R
Griffith, B
Sesky, T
Ostrowski, L
Starzl, TEtes11@pitt.eduTES11
Fung, JJ
Rao, AS
Centers: Other Centers, Institutes, Offices, or Units > Thomas E. Starzl Transplantation Institute
Date: 1 January 1999
Date Type: Publication
Journal or Publication Title: Journal of Leukocyte Biology
Volume: 66
Number: 2
Page Range: 310 - 314
DOI or Unique Handle: 10.1002/jlb.66.2.310
Institution: University of Pittsburgh
Refereed: Yes
ISSN: 0741-5400
Other ID: uls-drl:31735062127786, Starzl CV No. 2057
Date Deposited: 08 Apr 2010 17:35
Last Modified: 22 Jun 2021 14:56


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item